Allergan Inc. c. Canada (Health), 2012 FC 767: Comity or Tragedy?
A somewhat confusing victory for Allergan Inc. was won on June 18th, as the Honourable Justice Hughes upheld their patent on COMBIGAN despite the fact
A somewhat confusing victory for Allergan Inc. was won on June 18th, as the Honourable Justice Hughes upheld their patent on COMBIGAN despite the fact
Koninklijke Philips Electronics N.V. has survived a challenge against its “Display Device” patent by DSM IP Assets B.V. in a ruling by the Boards of
Canada has been lobbying to enter the Trans-Pacific Partnership (TPP), and its efforts have seemingly paid off with an exclusive invite to the secretive nine-member
At the Rio + 20 United Nations Conference on Sustainable Development — which followed by forty years the Stockholm Declaration of the United Nations Conference
In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on
On June 16, 2012, the Canada Gazette, published the proposed new regulations formalizing procedures before the Patented Medicine Prices Review Board (the Board). These proposed